|
Issue |
Title |
|
Vol 35, No 4 (2025) |
Cyst of Hattori: literature review and case presentation |
Abstract
PDF (Rus)
|
R. B. Berdnikov, K. A. Andryuschenko, N. S. Zavarov, E. M. Petrunina, A. V. Bazhenov, A. S. Romakhin |
|
Vol 35, No 4 (2025) |
Oxidative stress in patients with severe asthma |
Abstract
PDF (Rus)
|
Van Truong Nguyen, D. G. Soldatov |
|
Vol 35, No 3 (2025) |
Possibilities and prospects for the use of telemedicine technologies in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
F. T. Malykhin |
|
Vol 35, No 3 (2025) |
Lymphangioleiomyomatosis, sporadic and associated with tuberous sclerosis: a pulmonologist’s point of view |
Abstract
PDF (Rus)
|
M. A. Makarova, A. S. Belevskiy |
|
Online First |
Asthma and obesity: capabilities of bariatric surgery |
Abstract
PDF (Rus)
|
N. A. Karoli |
|
Vol 35, No 1 (2025) |
The role of the receptor for advanced glycation endproducts (RAGE) in the pathogenesis of asthma |
Abstract
PDF (Rus)
|
L. N. Sorokina, V. N. Mineev, A. S. Pavlova, V. I. Trofimov |
|
Vol 35, No 1 (2025) |
“COPD Navigator” – an innovative tool for doctor and patient |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, S N. Feigelman |
|
Vol 34, No 6 (2024) |
Respiratory sarcopenia: aspects of pathogenesis, approaches to diagnosis |
Abstract
PDF (Rus)
|
V. A. Sergeeva, N. K. Runikhina |
|
Vol 34, No 6 (2024) |
“Perplexing” cough |
Abstract
PDF (Rus)
|
I. B. Ponomareva, S. I. Glotov, O. M. Uryasev, S. V. Berstneva, V. A. Lunyakov |
|
Vol 34, No 6 (2024) |
New approaches to the treatment of pulmonary arterial hypertension |
Abstract
PDF (Rus)
|
M. V. Kchachaturov, N. A. Tsareva, S. N. Avdeev |
|
Vol 34, No 6 (2024) |
Biomarkers and genetic predictors of hypersensitivity pneumonitis |
Abstract
PDF (Rus)
|
N. V. Trushenko, A. M. Nikolenko, O. A. Suvorova, S. N. Avdeev |
|
Vol 34, No 5 (2024) |
Prospects of vaccination against pneumococcal infection based on the asthma phenotype |
Abstract
PDF (Rus)
|
A. M. Kostinov, A. Yu. Konishcheva |
|
Vol 34, No 5 (2024) |
Pulmonary hyalinizing granuloma: literature review and case presentation |
Abstract
PDF (Rus)
PDF (Rus)
|
A. V. Bazhenov, A. V. Kochurova, E. M. Petrunina, R. B. Berdnikov, E. A. Ovchinnikova |
|
Vol 34, No 4 (2024) |
Diagnosis and differential diagnosis of focal lung formations |
Abstract
PDF (Rus)
|
I. D. Lagkueva, N. V. Chernichenko, P. M. Kotlyarov, D. G. Soldatov, V. A. Solodkiy |
|
Vol 34, No 4 (2024) |
Lung cancer and pregnancy |
Abstract
PDF (Rus)
|
A. L. Chernyshova, A. A. Chernyakov, Ju. M. Trushjuk, O. S. Dil, A. E. Chernyshova |
|
Vol 34, No 4 (2024) |
Lung lesions in lymphoproliferative diseases |
Abstract
PDF (Rus)
|
V. V. Gainitdinova, S. N. Avdeev |
|
Vol 34, No 3 (2024) |
Use of inhaled nitric oxide in COVID-19 |
Abstract
PDF (Rus)
|
H. C. Nguyen, D. D. Pozdnyakova, I. A. Baranova, A. G. Chuchalin |
|
Vol 34, No 1 (2024) |
The potential use of N-acetylcysteine in respiratory conditions |
Abstract
PDF (Rus)
|
V. N. Antonov, G. L. Ignatova, M. S. Belsner |
|
Vol 33, No 6 (2023) |
Microflora of the lungs in health and disease, the impact of vaccination |
Abstract
PDF (Rus)
|
M. O. Zolotov, A. V. Zhestkov, A. V. Lyamin, V. D. Fedotov |
|
Vol 33, No 6 (2023) |
Oscillometry: clinical significance and applications |
Abstract
PDF (Rus)
|
L. D. Kiryukhina, A. V. Chernyak |
|
Vol 33, No 6 (2023) |
Pulmonary hemorrhage in cystic fibrosis: a review of current data |
Abstract
PDF (Rus)
|
M. M. Fedotova, A. A. Doronina |
|
Vol 33, No 6 (2023) |
Tiotropium bromide in the treatment of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
O. N. Titova, N. A. Kuzubova, A. G. Kozyrev |
|
Vol 34, No 1 (2024) |
“Ground glass opacity” sign in lung diseases: nuances of radiological diagnosis and correct interpretation |
Abstract
PDF (Rus)
|
A. A. Karpova, N. I. Sergeev, P. A. Nikitin, V. A. Solodkiy, P. M. Kotlyarov, N. V. Nudnov, Z. S. Tsallagova, D. G. Soldatov |
|
Vol 34, No 1 (2024) |
Influence of adipocytokines on the bronchopulmonary system in abdominal obesity |
Abstract
PDF (Rus)
|
A. D. Khudiakova, Yu. I. Ragino |
|
Vol 33, No 5 (2023) |
Pulmonary sequestrations |
Abstract
PDF (Rus)
|
A. V. Bazhenov, I. Ya. Motus, R. B. Berdnikov, A. S. Romahin |
|
Vol 33, No 5 (2023) |
Significance of N-acetylcysteine in clinical practice |
Abstract
PDF (Rus)
|
I. V. Leshchenko, N. A. Esaulova |
|
Vol 33, No 4 (2023) |
The role of metabolic syndrome factors in the pathogenesis of respiratory disorders |
Abstract
PDF (Rus)
|
O. V. Voronkova, Yu. G. Birulina, T. V. Saprina, I. E. Esimova, I. A. Osikhov |
|
Vol 33, No 4 (2023) |
Skin test based on Mycobacterium tuberculosis antigens (ESAT-6 and CFP-10) for the detection of tuberculosis infection in world practice |
Abstract
PDF (Rus)
|
O. E. Russkikh, E. V. Savintseva, D. A. Kudlay, N. P. Doktorova, P. G. Sysoev |
|
Vol 33, No 3 (2023) |
Eosinophilic granulomatosis with polyangiitis: etiopathogenesis, classification and clinical phenotypes |
Abstract
PDF (Rus)
|
E. Kh. Anaev, A. S. Belevskiy, N. P. Kniajeskaia |
|
Vol 33, No 3 (2023) |
Psychosomatic functional disorders in pulmonary practice |
Abstract
PDF (Rus)
|
S. I. Ovcharenko, D. V. Troshina, P. S. Sokolova, B. A. Volel |
|
Vol 33, No 3 (2023) |
Clinical significance of club cell protein CC16 in respiratory medicine |
Abstract
PDF (Rus)
|
M. M. Shapovalova, S. N. Avdeev, A. V. Budnevsky, L. V. Tribuntseva |
|
Vol 33, No 2 (2023) |
Randu - Osler - Weber disease (or hereditary hemorrhagic teleangectasia) with respiratory involvement |
Abstract
PDF (Rus)
|
Yu. L. Mizernitskiy, P. A. Shatokha, L. V. Sokolova |
|
Vol 33, No 2 (2023) |
Ciliated cell cultures for diagnosis of primary ciliary dyskinesia |
Abstract
PDF (Rus)
|
A. G. Demchenko, S. A. Smirnikhina |
|
Vol 33, No 2 (2023) |
Potential predictors of severe course and outcome of community-acquired pneumonia |
Abstract
PDF (Rus)
|
E. V. Volchkova, O. N. Titova, N. A. Kuzubova, E. S. Lebedeva |
|
Vol 33, No 1 (2023) |
Cellular metabolism and mitochondrial dysfunction in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
V. A. Nevzorova, T. A. Brodskaya, N. G. Plekhova, L. G. Priseko, A. A. Evstifeeva, A. E. Bagirova |
|
Vol 33, No 1 (2023) |
Treatment, diagnostics, and management of chronic obstructive pulmonary disease in women |
Abstract
PDF (Rus)
|
F. T. Malykhin, V. A. Baturin |
|
Vol 33, No 1 (2023) |
Improving the effectiveness of vaccination against viral and bacterial pathogens through micronutrient supplementation |
Abstract
PDF (Rus)
|
I. Yu. Torshin, O. A. Gromova, V. A. Maksimov, A. G. Chuchalin |
|
Vol 33, No 5 (2023) |
Differential diagnosis of community-acquired pneumonia and lung damage in respiratory viral infections, including COVID-19 |
Abstract
PDF (Rus)
|
D. A. Strelkova, A. A. Irgiskin, S. A. Rachina |
|
Vol 32, No 6 (2022) |
D-hypovitaminosis in working age patients with diseases of the respiratory organs: the risks and prevention |
Abstract
PDF (Rus)
|
L. K. Ibrayeva, D. Kh. Rybalkina, O. A. Evmenova, F. M. Turdaly, Zh. T. Ibragim |
|
Vol 32, No 6 (2022) |
The upper respiratory tract microbiome and its role in human health: barrier function |
Abstract
PDF (Rus)
|
E. V. Starikova, Yu. S. Galeeva, E. N. Il’ina |
|
Vol 32, No 6 (2022) |
Bilateral pleural effusion: etiology, diagnostics |
Abstract
PDF (Rus)
|
N. A. Stogova |
|
Vol 34, No 1 (2024) |
Various approaches to improving adherence of patients with tuberculosis. Prospects for the use of additive technologies in TB practice |
Abstract
PDF (Rus)
|
A. G. Naumov, A. S. Shprykov |
|
Vol 33, No 5 (2023) |
Gut–lung axis |
Abstract
PDF (Rus)
|
V. S. Belyaev, V. M. Chervinets, Yu. V. Chervinets |
|
Vol 33, No 4 (2023) |
The current status of antimicrobial resistance of Streptococcus pneumoniae and specific vaccine prevention of pneumococcal infection |
Abstract
PDF (Rus)
|
A. A. Kurkova, A. A. Muraviov, R. S. Kozlov |
|
Vol 34, No 1 (2024) |
The role of mast cells in the pathogenesis of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. V. Budnevsky, S. N. Avdeev, E. S. Ovsyannikov, I. A. Savushkina, Ya. S. Shkatova, V. V. Shishkina |
|
Vol 33, No 4 (2023) |
Eosinophilic granulomatosis with polyangiitis: diagnosis and treatment-related issues |
Abstract
PDF (Rus)
|
E. Kh. Anaev, N. P. Kniajeskaia |
|
No 4 (2001) |
Pleurisy in lung carcinoma |
Abstract
PDF (Rus)
|
A. L. Akopov |
|
No 4 (2001) |
To a problem of radiation-induced lung carcinoma |
Abstract
PDF (Rus)
|
A. E. Ali-Risa, M. V. Samsonova |
|
No 4 (2001) |
Short-acting ß2-agonists. Their influence on bronchial asthma course and mortality |
Abstract
PDF (Rus)
|
F. I. Petrovsky |
|
No 4 (2001) |
Community-acquired pneumonia in elderly patients. Strategy and tactics of antibacterial therapy |
Abstract
PDF (Rus)
|
L. I. Dvoretsky |
|
No 4 (2001) |
Clinical efficiency of formoterol when there is no response to salmeterol |
Abstract
PDF (Rus)
|
J. Kottakis, R. Woods, V. Le Gross, G. Della Cioppa |
|
No 3 (2001) |
Application of Levofloxacin in pulmonology |
Abstract
PDF (Rus)
|
S. V. Yakovlev, V. P. Yakovlev |
|
No 3 (2001) |
Optimal management of adult cystic fibrosis patients in an outpatient department |
Abstract
PDF (Rus)
|
L. A. Kronina, V. A. Samoilenko |
|
No 3 (2001) |
Intensive care for adult cystic fibrosis patients |
Abstract
PDF (Rus)
|
S. N. Avdeev, V. A. Samoilenko, E. L. Amelina, A. G. Chuchalin |
|
No 3 (2001) |
A role and a site of a combined therapy with Seretid (salmeterol/fluticazone propionate) in bronchial asthma treatment (review) |
Abstract
PDF (Rus)
|
V. l. Petrov, I. V. Smolenov, N. A. Smirnov |
|
No 3 (2001) |
Problems and achievements of gene therapy of cystic fibrosis |
Abstract
PDF (Rus)
|
P. S. Baranov, T. E. Ivashchenko, N. B. Glazkov |
|
No 2 (2001) |
Berotec H is a new form of non-freon metered dose inhaler |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov, I. L. Klyachkina |
|
No 2 (2001) |
AIDS, narcotic dependence and maternity |
Abstract
PDF (Rus)
|
K. I. Volkova, A. N. Kokosov |
|
No 1 (2001) |
An application of severity assessment scores in intensive therapy and pulmonology |
Abstract
PDF (Rus)
|
S. N. Avdeev, A. G. Chuchalin |
|
No 1 (2001) |
Lung diseases in the Great Patriotic War (using Soviet medicine data from the period of the Great Patriotic War, 1941-1945) |
Abstract
PDF (Rus)
|
E. Yu. Zhavoronkova |
|
No 1 (2001) |
Difficult asthma |
Abstract
PDF (Rus)
|
L. M. Ogorodova, F. I. Petrovsky, Yu. I. Petrovskaya, O. S. Kobyakova |
|
No 1 (2001) |
Fenspirid (Erespal) in a treatment of pulmonary obstructive diseases |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 3 (2000) |
Population-and-genetic approach to prognosing of diabetes development in oronchial asthma patients |
Abstract
PDF (Rus)
|
G. Yu. Babadzhanova |
|
No 3 (2000) |
Biology of alveolocytes type II isolated from lung and cultured in vitro. 2. Morphological-and-functional peculiarities of isolated alveolocytes type II. |
Abstract
PDF (Rus)
|
L. K. Romanova |
|
No 2 (2000) |
New abilities of anti-histamine drugs |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 2 (2000) |
Tailed in bronchial asthma pharmacological management |
Abstract
PDF (Rus)
|
A. S. Sokolov |
|
No 1 (2000) |
Fixed combinations of inhaled steroids and long-acting β2-agonists in bronchial asthma treatment |
Abstract
PDF (Rus)
|
A. G. Chuchalin, E. N. Kalmanova, Z. R. Aisanov, O. Yu. Stoulova, M. V. Beda |
|
No 4 (1999) |
Diagnostic value of computed and magnetic resonance tomography in pathology of lungs and mediastinum |
Abstract
PDF (Rus)
|
P. M. Kotlyarov, N. K. Sviridov, N. L. Shitnanovsky |
|
No 4 (1999) |
The role of Oxis Turbuhaler (Formoterol) in bronchial asthma therapy |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov |
|
No 4 (1999) |
Modern laboratory diagnostics of the respiratory tuberculosis |
Abstract
PDF (Rus)
|
V. I. Golyshevskaya, L. N. Chernousova, Ye. F. Shashkina, O. O. Kovalenko, Ye. Ye. Larionava |
|
No 2 (1999) |
Pharmacokinetik parameters of modern inhaled glucocorticoids |
Abstract
PDF (Rus)
|
A. N. Tsoy |
|
No 2 (1999) |
Formation and role of biological defects for bronchial asthma appearance and development |
Abstract
PDF (Rus)
|
V. I. Nemtsov, G. B. Fedoseev |
|
No 2 (1999) |
Use of quinolones for treatment of in-patient and out-patient pneumonias |
Abstract
PDF (Rus)
|
Yu. B. Belousov, Zh. A. Galeeva, O. V. Efremenkova |
|
No 1 (1999) |
Systems for drugs delivery to airways by inhalation |
Abstract
PDF (Rus)
|
L. M. Ogorodova |
|
No 1 (1999) |
Intracellular signal systems and lung pathology. Ion transport in airway epithelium cells |
Abstract
PDF (Rus)
|
S. N. Orlov, I. A. Baranova, A. G. Chuchalin |
|
No 4 (1998) |
Biopsy in pulmonology |
Abstract
PDF (Rus)
|
I. Ya. Motus |
|
No 4 (1998) |
Preoperative monitoring of the external respiration function and reserves in lung surgery |
Abstract
PDF (Rus)
|
L. K. Bronskaya, A. Ya. Samokhin, V. S. Sokolova, M. I. Chushkin |
|
No 4 (1998) |
Is the Deflatsacort a sintetic glucocorticoid with the less side effects? |
Abstract
PDF (Rus)
|
G. Yu. Babadzhanova, A. G. Chuchalin, B. Allolio |
|
No 2 (1998) |
Life quality of patients with chronic obstructive pulmonary diseases |
Abstract
PDF (Rus)
|
E. I. Shmelev, M. V. Beda, Paul W. Sones, Rob Thwaites, A. G. Thwaites |
|
No 2 (1998) |
Induced sputum method in evaluation of airway inflammatory intensity |
Abstract
PDF (Rus)
|
S. N. Avdeev, E. Kh. Anaev, A. G. Chuchalin |
|
No 1 (1998) |
Leucotriene antagonists and inhibitors in bronchial asthma treatment |
Abstract
PDF (Rus)
|
V. L. Kovaleva, A. G. Chuchalin, N. A. Kolganova |
|
No 1 (1998) |
Aldecid in bronchial asthma treatment |
Abstract
PDF (Rus)
|
I. M. Kakhnovsky, V. F. Marinin, S. V. Arkhipova, L. A. Sorokina |
|
No 4 (1997) |
The Pathogenesis of Pneumoconiosis: Contemporary Ideas and a Retrospect |
Abstract
PDF (Rus)
|
Y. A. Loschilov |
|
No 4 (1997) |
AIDS: Pneumocystal Pneumonia |
Abstract
PDF (Rus)
|
K. I. Volkova, A. N. Kokosova |
|
No 3 (1997) |
Respiratory effects of ozone |
Abstract
PDF (Rus)
|
S. O. Aleinikov, A. G. Chuchalin |
|
No 3 (1997) |
Advantages and disadvantages of appliances for individual inhalation therapy |
Abstract
PDF (Rus)
|
A. N. Tsoi |
|
No 3 (1997) |
Immunopathology molecular and cellular mechanisms for bronchial asthma patients |
Abstract
PDF (Rus)
|
M. P. Potapnev, D. V. Pechkovsky |
|
No 2 (1997) |
Nitric oxide and lung hemocirculation |
Abstract
PDF (Rus)
|
V. A. Nevzorova, B. I. Geltser |
|
No 2 (1997) |
Treatment for a sleep apnea syndrome with the constant positive pressure in respioratory tracts |
Abstract
PDF (Rus)
|
S. L. Babak, A. M. Belov, R. V. Buzunov, R. A. Grigoriants, L. I. Kozlova, S. V. Stebletsov, A. G. Chuchalin |
|
No 4 (1995) |
Inhalational glucocorticoids in broncial asthma therapy |
Abstract
PDF (Rus)
|
O. A. Sutochnikova, A. L. Cherniayev, A. G. Chuchalin |
|
No 4 (1995) |
Pulmonary hemodynamics in patients with sleep apnea syndrome |
Abstract
PDF (Rus)
|
A. D. Palman, T. S. Eligulashvili |
|
No 2 (1995) |
Intracellular signaling systems and pulmonary pathology. I. Smooth muscle cells |
Abstract
PDF (Rus)
|
S. N. Orlov, I. A. Baranova, A. G. Chuchalin |
|
No 2 (1995) |
Respiratory supairments in prematurely born infants |
Abstract
PDF (Rus)
|
V. N. Suchkova, M. G. Viaskova |
|
No 1 (1995) |
The study of antioxidant activity of biological and pharmacologic aspects |
Abstract
PDF (Rus)
|
E. S. Dremina, V. S. Sharov, Y. A. Vladimirov |
|
No 1 (1995) |
The free radical reaction development in pulmonary cells during asbestos influence (rewiew) |
Abstract
PDF (Rus)
|
S. K. Sohodajeva |
|
No 4 (1994) |
Specific immune therapy of bronchial asthma |
Abstract
PDF (Rus)
|
D. S. Nugmanova |
|
No 4 (1994) |
The structural-functional characteristics of eosynophils and their role in the bronchial asthma pathogenesis and treatment |
Abstract
PDF (Rus)
|
E. H. Anaev, A. L. Cherniaev, A. R. Tatarskiy, L. M. Voronina |
|
No 4 (1994) |
The tests of the specific bronchial challenge in the bronchial asthma diagnostics |
Abstract
PDF (Rus)
|
D. G. Soldatov, I. A. Kusakina, E. V. Babarskov |
|
No 3 (1994) |
Cystic fibrosis in adults: ethyology, pathogenesis, perspectives of treatment |
Abstract
PDF (Rus)
|
A. G. Chuchalin, L. M. Voronina, L. A. Kronina, M. V. Samsonova |
|
No 3 (1994) |
Moder approaches to treatment of infectional process during cystic fibrosis (Review) |
Abstract
PDF (Rus)
|
L. A. Jelenina, T. E. Gembitskaya |
|
No 3 (1994) |
Antimicrobic therapy during cystic fibrosis in infants |
Abstract
PDF (Rus)
|
L. A. Shabalova |
|
No 2 (1994) |
Respiration function and blood gas content during heart rhythm and conductivity impairments |
Abstract
PDF (Rus)
|
I. V. Maev, E. V. Filippova |
|
No 2 (1994) |
Hypersencitivity and hyperreactivity of cholinergic bronchial receptors and nonspecific pulmonary diseases |
Abstract
PDF (Rus)
|
D. A. Shikhnebiev |
|
No 1 (1994) |
The prevalence of chronic bronchitis and bronchial asthma (data of epydemiological studies) |
Abstract
PDF (Rus)
|
T. N. Bilichenko |
|
No 1 (1994) |
Some aspects of physiologic and toxic effects of hyperoxia |
Abstract
PDF (Rus)
|
R. S. Vinitskaia, O. V. Alexandrov, G. V. Nekliudova, J. K. Naumenko |
|
Vol 30, No 4 (2020) |
The syndrome of respiratory failure in acute stroke: new diagnostic approaches |
Abstract
PDF (Rus)
|
A. G. Chuchalin, T. G. Кim, L. V. Shogenova, M. Yu. Martynov, E. I. Gusev |
|
No 6 (2004) |
Endobronchial treatment methods of early central lung cancer |
Abstract
PDF (Rus)
|
V. V. Sokolov |
|
No 2 (2004) |
Displastia of connective tissue: pulmonological aspects |
Abstract
PDF (Rus)
|
G. I. Nechaeva, I. A. Viktorova, I. V. Druk, M. V. Vershinina |
|
No 3 (2003) |
Lung function assessment in pre-school children |
Abstract
PDF (Rus)
|
Dundas Isobel, McKenzie Sheila |
|
No 2 (2002) |
A role of Foradil (formoterol fumarate) in therapy of bronchial asthma and chronic obstructive lung disease |
Abstract
PDF (Rus)
|
N. P. Knyazheskaya |
|
No 4 (2002) |
The role of almitrin in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 1 (1992) |
Effects of smoking on immune and non-specific resistance |
Abstract
PDF (Rus)
|
N. V. Golub |
|
No 2 (2012) |
Inflammatory biomarkers in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
I. V. Leshchenko, I. I. Baranova |
|
No 6 (2012) |
Small airways in chronic obstructive pulmonary disease as a core target of effective therapy |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 4 (2013) |
Novel effects of antiinflammatory therapy of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 3 (2011) |
Current approach to chemotherapy of pulmonary tuberculosis |
Abstract
PDF (Rus)
|
I. A. Vasilieva, A. G. Samoilova |
|
No 6 (2011) |
Long-acting β2-agonists in treatment of obstructive lung diseases |
Abstract
PDF (Rus)
|
N. M. Nenasheva |
|
No 6 (2014) |
Comorbidity of asthma and diabetes: synergism or antagonism? |
Abstract
PDF (Rus)
|
V. A. Ivanov, L. N. Sorokina, V. N. Mineev, N. E. Shestakova, A. A. Bystrova, V. I. Trofimov |
|
Vol 25, No 6 (2015) |
New perspectives in therapy of chronic obstructive pulmonary disease: revolving around aclidinium bromide |
Abstract
PDF (Rus)
|
S. N. Avdeev, N. V. Trushenko |
|
Vol 26, No 4 (2016) |
Community-acquired pneumonia in adult HIV-infected patients: course, treatment, and prevention |
Abstract
PDF (Rus)
|
V. N. Zimina, A. V. Astaf'ev |
|
Vol 27, No 2 (2017) |
Idiopathic pulmonary arterial hypertension: current approach to diagnosis and pharmacological treatment |
Abstract
PDF (Rus)
|
N. A. Tsareva |
|
Vol 28, No 1 (2018) |
Mild bronchial asthma: the present and the future |
Abstract
PDF (Rus)
|
S. N. Avdeev, Z. R. Aisanov, A. S. Belevskiy, A. M. Kulbaisov, O. M. Kurbacheva, I. V. Leshchenko, N. M. Nenasheva, R. S. Fassakhov |
|
Vol 28, No 6 (2018) |
Diagnostic role of cardiopulmonary exercise testing in patients with sarcoidosis |
Abstract
PDF (Rus)
|
L. B. Postnikova, A. L. Gudim, V. A. Kostrov, I. A. Dorovskoy, S. K. Soodayeva, N. A. Popova |
|
Vol 29, No 5 (2019) |
Perspectives of treatment with probiotics in acute respiratory infections |
Abstract
PDF (Rus)
|
V. T. Ivashkin, O. Yu. Zol’nikova, N. D. Potskhverashvili, N. I. Kokina, E. L. Buyeverova, A. V. Sedova, A. S. Trukhmanov |
|
Vol 30, No 5 (2020) |
Imaging of lung pathology in COVID-19 (literature review and own data) |
Abstract
PDF (Rus)
PDF (Eng)
|
I. E. Tyurin, A. D. Strutynskaya |
|
No 2 (2008) |
Challenge bronchomotor tests in functional assessment of respiratory system in sportsmen |
Abstract
PDF (Rus)
|
T. V. Gavrish, I. V. Gavrish |
|
No 2 (2007) |
Antiinflammatory drug fenspirid |
Abstract
PDF (Rus)
|
A. A. Visel, I. Yu. Visel, I. Yu. Pronina |
|
No 6 (2007) |
Epidemiology of COPD: state of the art of an actual problem |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov, A. V. Vorobiev |
|
Vol 30, No 4 (2020) |
Risk factors and prevention of nosocomial pneumonia in polytrauma |
Abstract
PDF (Rus)
|
Yu. G. Shapkin, P. A. Seliverstov, N. Yu. Stekol'nikov |
|
No 6 (2004) |
Tumor and cicatricial stenoses of the trachea and large bronchi: main principles of endosurgical treatment |
Abstract
PDF (Rus)
|
A. A. Ovchinnikov, R. V. Seredin |
|
No 6 (2003) |
Spiriva is an effective drug reducing dyspnoe and exacerbation rate in COPD (clinical search findings) |
Abstract
PDF (Rus)
|
S. I. Ovcharenko, E. P. Golikova |
|
No 3 (2003) |
Beclojet: new techniques of delivery of inhaled glucocorticosteroids |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 2 (2002) |
Allergy to latex |
Abstract
PDF (Rus)
|
O. S. Vasilieva, G. A. Kazakova, S. Z. Batyn |
|
No 4 (2002) |
Formoterol (foradil) in treatment of chronic obstructive pulmonary disease by evidence-based medicine |
Abstract
PDF (Rus)
|
A. N. Tsoy, V. V. Arkhipov |
|
No 2 (1992) |
Outcomes of bronchial asthma in children |
Abstract
|
Z. S. Umarova |
|
No 2 (2012) |
Synanthropic arthropods and their role in occurrence of allergic diseases |
Abstract
PDF (Rus)
|
V. M. Berzhets, S. V. Khlgatyan, I. S. Kropotova, O. V. Radikova |
|
No 6 (2012) |
Asthma control and small airways: is there relationship? |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov, Yu. G. Belotserkovskaya |
|
No 4 (2013) |
Strategy of rational antibacterial therapy of acute exacerbation of chronic obstructive pulmonary disease: an approach based on minimal hazard risk |
Abstract
PDF (Rus)
|
I. A. Guchev, S. V. Sidorenko |
|
No 3 (2011) |
Phenotypes of chronic obstructive pulmonary disease and the ECLIPSE study: preliminary results |
Abstract
PDF (Rus)
|
S. I. Ovcharenko |
|
No 2 (2011) |
OPPORTUNITY TO CONTROL ASTHMA: A ROLE OF SMALL AIRWAYS |
Abstract
PDF (Rus)
|
A. V. Budnevsky, V. T. Burlachuk, I. A. Olysheva, E. V. Tokmachev |
|
No 6 (2014) |
Blood lactate and the lungs: from theory to practice |
Abstract
PDF (Rus)
|
E. Kh. Anaev |
|
Vol 25, No 6 (2015) |
Mechanisms of antioxidative stress caused by environmental air pollution: possibility of antioxidant defense |
Abstract
PDF (Rus)
|
S. K. Soodaeva, L. Yu. Nikitina, I. A. Klimanov |
|
Vol 26, No 4 (2016) |
DuoResp Spiromax® is a new intuitive dosing dry powder inhaler of budesonide and formoterol |
Abstract
PDF (Rus)
|
A. A. Vizel', I. Yu. Vizel' |
|
Vol 27, No 2 (2017) |
Non invasive ventilation in patients with chronic obstructive pulmonary disease in a hospital and at home |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 28, No 1 (2018) |
The epoch of dual bronchodilation: the first direct comparisons and meta-analyzes |
Abstract
PDF (Rus)
|
A. A. Vizel', I. Yu. Vizel' |
|
Vol 28, No 6 (2018) |
Preventive immunization against respiratory infections in patients with cystic fibrosis |
Abstract
PDF (Rus)
|
D. A. Blagovidov, K. V. Mashilov, A. M. Kostinov |
|
Vol 30, No 5 (2020) |
Non-invasive ventilation in patients with novel coronavirus infection COVID-19 |
Abstract
PDF (Rus)
PDF (Eng)
|
Sergey N. Avdeev |
|
No 3 (2008) |
Control of asthma and its achievement |
Abstract
PDF (Rus)
|
N. M. Nenasheva |
|
No 2 (2007) |
Reduction of exacerbations of COPD under long-term administration of N-acetylcysteine |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 6 (2007) |
Budesonide / formoterol as an inhaler for basic therapy and relief of asthma symptoms (SMART strategy) |
Abstract
PDF (Rus)
|
N. P. Knyazheskaya |
|
Vol 30, No 5 (2020) |
Chronic obstructive pulmonary disease and COVID-19: topical issues |
Abstract
PDF (Rus)
PDF (Eng)
|
A. M. Shchikota, I. V. Pogonchenkova, E. A. Turova, M. A. Rassulova, S. A. Gumenyuk |
|
No 6 (2004) |
A role of lung hyperinflation in pathogenesis of chronic obstructive pulmonary disease. A role of supporting therapy in the reduction of lung hyperinflation |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 6 (2003) |
Severe bronchial asthma: pathogenesis, clinical features and management |
Abstract
PDF (Rus)
|
N. L. Shaporova, M. A. Petrova, V. I. Trofimov |
|
No 3 (2003) |
Mechanisms of development of pulmonary hypertension in chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
M. A. Borodina, L. A. Merzlikin, V. V. Schetinin, S. G. Ivanov, V. I. Borodina |
|
No 2 (2002) |
Benacort in the therapy of bronchial asthma |
Abstract
PDF (Rus)
|
N. A. Raspopina, I. O. Shuginin, S. A. Vitushko, N. B. Biryukova, A. A. Efanov |
|
No 2 (1992) |
“Second messengers” in the process of development of immune response |
Abstract
|
N. V. Basilevitch, Yu. K. Novikov |
|
No 1 (2013) |
How can we improve asthma control without escalating therapy? |
Abstract
PDF (Rus)
|
A. I. Sinopalnikov, Yu. G. Belotserkovskaya |
|
No 2 (2013) |
Peroxisome proliferator-activated receptors in physiology and pathology of the lung |
Abstract
PDF (Rus)
|
M. S. Rasin |
|
No 4 (2013) |
Tobramycin inhalations in therapy of chronic infection Pseudomonas aeruginosa in cystic fibrosis |
Abstract
PDF (Rus)
|
E. L. Amelina, S. A. Krasovsky |
|
No 3 (2011) |
Abilities to achieve stable control of asthma with regard to variability of the disease |
Abstract
PDF (Rus)
|
N. M. Nenasheva |
|
No 4 (2014) |
On contradictions in clinical guidelines on chemotherapy of patients with pulmonary tuberculosis in Russian Federation according to evidence!based medicine: meta!analysis and systematic review |
Abstract
PDF (Rus)
|
V. Yu. Mishin |
|
Vol 25, No 1 (2015) |
A role of fixed combinations of long-acting anticholinergics and long-acting #b2-agonists in therapy of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 26, No 1 (2016) |
Perspectives of pharmacological therapy of chronic obstructive pulmonary disease: opportunities of dual bronchodilation and a role of inhaled steroids. Expert Council Consensus |
Abstract
PDF (Rus)
|
S. N. Avdeev, Z. R. Aysanov, A. S. Belevskiy, A. A. Vizel', G. L. Ignatova, N. P. Knyazheskaya, I. V. Leshchenko, S. I. Ovcharenko, V. I. Trofimov, E. I. Shmelev |
|
Vol 26, No 5 (2016) |
A ROLE OF HYPERTONIC SALINE SOLUTION IN TREATMENT OF CYSTIC FIBROSIS |
Abstract
PDF (Rus)
|
N. Yu. Kashirskaya, V. D. Sherman, N. I. Kapranov, E. I. Kondrat'eva, S. A. Krasovskiy, E. L. Amelina |
|
Vol 27, No 2 (2017) |
Granulomatous lung diseases |
Abstract
PDF (Rus)
|
M. V. Samsonova, A. L. Chernyaev |
|
Vol 28, No 1 (2018) |
Acute exacerbations as a poor prognostic factor of chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
Aung Kyaw Soe |
|
Vol 28, No 6 (2018) |
Treatment of upper airway diseases in patients with cystic fibrosis |
Abstract
PDF (Rus)
|
G. L. Shumkova, E. L. Amelina, V. M. Svistushkin, S. A. Krasovskiy, N. Yu. Kashirskaya, E. V. Sin’kov |
|
Vol 29, No 6 (2019) |
Small respiratory passages dysfunction in bronchial asthma |
Abstract
PDF (Rus)
|
O. Yu. Kytikova, M. V. Antonyuk, B. I. Gel'tser, E. E. Mineeva, T. A. Gvozdenko |
|
Vol 30, No 5 (2020) |
COVID-19 and children |
Abstract
PDF (Rus)
PDF (Eng)
|
L. S. Namazova-Baranova, A. A. Baranov |
|
No 3 (2008) |
Choice of pharmacotherapy in severe asthma |
Abstract
PDF (Rus)
|
F. I. Petrovsky, L. M. Ogorodova |
|
No 2 (2007) |
Symbicort (budesonide / formoterol) as a single inhaler for maintenance and reliever therapy of asthma |
Abstract
PDF (Rus)
|
A. G. Chuchalin, A. N. Tsoy, V. V. Arkhipov |
|
No 6 (2007) |
Telemedicine in pulmonology |
Abstract
PDF (Rus)
|
I. Yu. Tarasenko |
|
Vol 30, No 6 (2020) |
First triple therapy in one inhaler for COPD patients: treatment approach (scientific data overview) |
Abstract
PDF (Rus)
|
S. N. Avdeev, Z. R. Aisanov, A. V. Emelyanov |
|
No 6 (2004) |
New opportunities to use fluoroquinolones in pulmonology |
Abstract
PDF (Rus)
|
L. S. Strachunsky, A. V. Veselov, V. A. Krechikov |
|
No 6 (2003) |
Clarithromycin is a semisynthetic macrolid antimicrobial drug for treatment of community acquired respiratory infections |
Abstract
PDF (Rus)
|
S. V. Yakovlev, N. S. Yutanova |
|
No 1 (2003) |
A study of quality of life in respiratory diseases |
Abstract
PDF (Rus)
|
O. A. Sukhovskaya, M. M. Ilkovich, V. A. Ignatiev |
|
No 3 (2002) |
Anti-histamine drugs in a doctor’s daily practice |
Abstract
PDF (Rus)
|
O. V. Zaitseva |
|
No 4 (1992) |
Mechanisms of respiratory muscle fatigue |
Abstract
PDF (Rus)
|
A. A. Bichev, A. G. Chuchalin |
|
No 1 (2013) |
Safety and efficacy as fundamental choice of inhaled steroids for treatment of childhood asthma |
Abstract
PDF (Rus)
|
N. A. Geppe, N. G. Kolosova |
|
No 2 (2013) |
Probable role of apelinergic system in occurrence of pulmonary diseases |
Abstract
PDF (Rus)
|
V. N. Mineev, T. M. Lalaeva, A. A. Kuzmina |
|
No 5 (2013) |
Pharmacotherapy of radiation-induced pulmonary lesions in oncologic patients |
Abstract
PDF (Rus)
|
M. G. Sycheva, T. I. Grushina |
|
No 2 (2014) |
|
Details
PDF (Rus)
|
V. I. Trofimov, L. N. Sorokina |
|
No 4 (2014) |
Interstitial lung disease in elderly |
Abstract
PDF (Rus)
|
L. I. Dvoretskiy |
|
Vol 25, No 1 (2015) |
Outcomes of community-acquired pneumonia |
Abstract
PDF (Rus)
|
E. S. Korovkina |
|
Vol 26, No 1 (2016) |
Clinical efficacy and cost-effectiveness of therapy for chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
A. S. Belevskiy |
|
Vol 26, No 5 (2016) |
PREVENTION OF ACUTE EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 27, No 2 (2017) |
Nitrosative and oxidative stresses in respiratory diseases |
Abstract
PDF (Rus)
|
S. K. Soodaeva, I. A. Klimanov, L. Yu. Nikitina |
|
Vol 28, No 1 (2018) |
Physical rehabilitation of patients with chronic respiratory diseases: the optimal organization under limited resources |
Abstract
PDF (Rus)
|
M. G. Sycheva |
|
Vol 29, No 1 (2019) |
Current approaches to pharmacological treatment of adult patients with bronchiectasis |
Abstract
PDF (Rus)
|
S. Yu. Chikina, S. N. Avdeev |
|
Vol 29, No 6 (2019) |
Ectopic olfactory receptors in the respiratory system |
Abstract
PDF (Rus)
|
V. N. Mineev |
|
No 6 (2010) |
Роль малых дыхательных путей при бронхиальной астме |
Details
PDF (Rus)
|
|
|
No 3 (2008) |
Drug therapy of stable chronic obstructive pulmonary disease |
Abstract
PDF (Rus)
|
I. V. Leshchenko |
|
No 2 (2007) |
COPD as a systemic disease |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
No 6 (2007) |
GINA 2006: asthma control as the main goal of treatment and criterion of efficacy of the therapy |
Abstract
PDF (Rus)
|
L. M. Ogorodova, I. A. Deev, P. A. Selivanova |
|
Vol 30, No 6 (2020) |
Disease-modifying treatment of asthma: role of omalizumab |
Abstract
PDF (Rus)
|
G. A. Novik, S. N. Avdeev, Yu. V. Solovkina |
|
No 5 (2004) |
Field evaluation of dyspnea and functional status in respiratory pathology (review) |
Abstract
PDF (Rus)
|
S. Yu. Chikina |
|
No 5 (2003) |
A Influence of Spiriva on lung function parameters: clinical research data |
Abstract
PDF (Rus)
|
Z. R. Aisanov |
|
No 1 (2003) |
To medication influence on dyspnoe |
Abstract
PDF (Rus)
|
V. N. Abrosimov, A. V. Shutov |
|
No 3 (2002) |
Foradil (formoterol fumarate): a significance and a place in the therapy of asthma and COPD |
Abstract
PDF (Rus)
|
S. N. Avdeev |
|
Vol 32, No 5 (2022) |
Chronic obstructive pulmonary disease and COVID-19 |
Abstract
PDF (Rus)
|
E. A. Zaryanova, G. L. Osipova, V. V. Osipova |
|
1 - 200 of 469 Items |
1 2 3 > >>
|